Raymond James Financial Services Advisors, Inc. - BLUEPRINT MEDICINES CORP ownership

BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 214 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
Raymond James Financial Services Advisors, Inc. ownership history of BLUEPRINT MEDICINES CORP
ValueSharesWeighting
Q3 2023$2,144,846
-44.9%
42,709
-30.7%
0.00%
-42.9%
Q2 2023$3,896,090
+144.9%
61,647
+74.4%
0.01%
+133.3%
Q1 2023$1,590,621
+1.8%
35,355
-0.8%
0.00%0.0%
Q4 2022$1,561,958
-46.3%
35,653
-19.3%
0.00%
-50.0%
Q3 2022$2,911,000
+40.6%
44,186
+7.8%
0.01%
+20.0%
Q2 2022$2,070,000
-2.9%
40,975
+22.8%
0.01%
+25.0%
Q1 2022$2,132,000
-40.8%
33,374
-0.8%
0.00%
-42.9%
Q4 2021$3,603,000
+26.6%
33,637
+21.6%
0.01%
+16.7%
Q3 2021$2,845,000
+58.7%
27,668
+35.7%
0.01%
+50.0%
Q2 2021$1,793,000
-7.1%
20,387
+2.6%
0.00%0.0%
Q1 2021$1,931,000
-35.4%
19,862
-25.5%
0.00%
-42.9%
Q4 2020$2,989,000
-6.7%
26,649
-22.9%
0.01%
-22.2%
Q3 2020$3,205,000
+6.8%
34,574
-10.1%
0.01%
-10.0%
Q2 2020$3,000,000
+28.4%
38,458
-3.7%
0.01%0.0%
Q1 2020$2,336,000
+40.0%
39,944
+91.8%
0.01%
+100.0%
Q4 2019$1,668,000
+717.6%
20,824
+649.6%
0.01%
+400.0%
Q3 2019$204,000
-32.0%
2,778
-12.7%
0.00%0.0%
Q2 2019$300,000
-42.9%
3,181
-69.3%
0.00%
-75.0%
Q2 2017$525,00010,3600.00%
Other shareholders
BLUEPRINT MEDICINES CORP shareholders Q1 2023
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 423,012$41,129,0007.43%
Eagle Health Investments LP 133,163$12,947,0005.08%
DAFNA Capital Management LLC 207,911$20,215,0004.80%
Casdin Capital, LLC 1,550,000$150,707,0004.49%
SIB LLC 65,151$6,335,0003.72%
CADIAN CAPITAL MANAGEMENT, LP 913,702$88,839,0003.29%
Integral Health Asset Management, LLC 117,500$11,425,0003.26%
Rock Springs Capital Management LP 746,732$72,605,0001.58%
Avidity Partners Management LP 546,000$53,088,0001.47%
Zebra Capital Management LLC 12,698$1,235,0001.36%
View complete list of BLUEPRINT MEDICINES CORP shareholders